Hosoda K, Feussner G K, Rydelek-Fitzgerald L, Fishman P H, Duman R S
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
J Neurochem. 1994 Nov;63(5):1635-45. doi: 10.1046/j.1471-4159.1994.63051635.x.
Exposure of rat C6 glioma cells to either agonists or agents that increase cyclic AMP levels leads to down-regulation of beta 1-adrenergic receptors (beta 1 AR) as measured by loss of radioligand binding sites. The present study examines the influence of isoproterenol and forskolin treatment on levels of beta 1 AR mRNA, mRNA stability, and gene transcription rate. Isoproterenol treatment of C6 cells altered beta 1 AR mRNA levels in a biphasic manner; i.e., short-term exposure (30-60 min) increased by 50%, whereas longer exposure (2-6 h) decreased by 50% the levels of beta 1 AR mRNA. The extent of both the up- and down-regulation was dependent on agonist concentration. Similar regulation of beta 1 AR mRNA was observed in forskolin-treated cells. Pretreatment of the cells with Pseudomonas exotoxin A, a potent inhibitor of protein synthesis, completely blocked isoproterenol- and forskolin-mediated down-regulation of beta 1 AR mRNA, and thereby potentiated the increase in receptor mRNA up to fourfold over the 6-h time course. The mechanisms underlying beta 1 AR mRNA down-regulation were examined. The half-life of beta 1 AR mRNA was slightly increased (from 61 to 77 min) after a 2-h exposure of the cells to either isoproterenol or forskolin. Nuclear run-on analysis demonstrated that the rate of beta 1 AR gene transcription was increased after isoproterenol incubation for 60 min, but then decreased after 90-240 min, consistent with the time course for up- and down-regulation of beta 1 AR mRNA. Isoproterenol treatment (120 min) also decreased the level of beta 1 AR nascent transcripts, purified by affinity chromatography of RNA isolated from 4-thiouridine-pulsed cells. The results demonstrate that beta 1 AR mRNA has a relatively short half-life and that agonist regulation of beta 1 AR mRNA is mediated by activation of the cyclic AMP system. Moreover, the results indicate that agonist regulation of beta 1 AR mRNA occurs at the level of beta 1 AR gene transcription, not mRNA stability. Finally, the observed requirement for protein synthesis indicates that beta 1 AR mRNA down-regulation may be mediated by the induction of a repressor of the beta 1 AR gene.
将大鼠C6胶质瘤细胞暴露于激动剂或能提高环磷酸腺苷(cAMP)水平的试剂中,会导致β1 - 肾上腺素能受体(β1AR)下调,这可通过放射性配体结合位点的丧失来衡量。本研究考察了异丙肾上腺素和福斯高林处理对β1AR mRNA水平、mRNA稳定性及基因转录速率的影响。用异丙肾上腺素处理C6细胞会以双相方式改变β1AR mRNA水平;即短期暴露(30 - 60分钟)会使其增加50%,而较长时间暴露(2 - 6小时)则会使其水平降低50%。上调和下调的程度均取决于激动剂浓度。在经福斯高林处理的细胞中也观察到了β1AR mRNA的类似调节。用强效蛋白质合成抑制剂铜绿假单胞菌外毒素A预处理细胞,完全阻断了异丙肾上腺素和福斯高林介导的β1AR mRNA下调,从而在6小时的时间进程中使受体mRNA的增加增强了四倍。研究了β1AR mRNA下调的潜在机制。细胞在暴露于异丙肾上腺素或福斯高林2小时后,β1AR mRNA的半衰期略有增加(从61分钟增至77分钟)。细胞核连续分析表明,异丙肾上腺素孵育60分钟后β1AR基因转录速率增加,但90 - 240分钟后降低,这与β1AR mRNA上调和下调的时间进程一致。异丙肾上腺素处理(120分钟)还降低了通过对从4 - 硫尿苷脉冲细胞中分离的RNA进行亲和层析纯化得到的β1AR新生转录本的水平。结果表明β1AR mRNA半衰期相对较短,且激动剂对β1AR mRNA的调节是由环磷酸腺苷系统的激活介导的。此外,结果表明激动剂对β1AR mRNA的调节发生在β1AR基因转录水平,而非mRNA稳定性水平。最后,观察到的对蛋白质合成的需求表明β1AR mRNA下调可能是由β1AR基因阻遏物的诱导介导的。